
Armada III (AACI) to Combine with Brains Bioceutical in $892M Deal
Armada III (NASDAQ:AACI) has entered into a definitive agreement to combine with drug developer Brains Bioceutical at a pro forma enterprise value of $891.8 million. Brains Bioceutical has built out the manufacturing base to provide medical-grade cannabinoid ingredients to the biotech and consumer industries while pursuing its own potential drug candidates. More
Nicholas Alan Clayton·Nov 6







